Change in QoL scores after ablation: relationship with clinical parameters and ablation outcome
| AFEQT R/T (P) | PCS R/T (P) | MCS R/T (P) | |
|---|---|---|---|
| Age | −0.02 (0.87) | 0.05 (0.70) | −0.16 (0.15) |
| Female gender | 0.28 (0.78) | −1.14 (0.26) | 1.31 (0.19) |
| Persistent AF | 1.48 (0.14) | −0.03 (0.98) | 1.33 (0.19) |
| AF history | −0.09 (0.44) | −0.18 (0.11) | −0.01 (0.96) |
| LA volume | <−0.01 (0.98) | 0.06 (0.63) | −0.34 (<0.01) |
| LVEF | 0.06 (0.61) | −0.05 (0.68) | 0.10 (0.38) |
| Hypertension | −0.57 (0.57) | −0.01 (0.99) | −0.49 (0.63) |
| Diabetes | 1.31 (0.20) | 0.95 (0.34) | −0.23 (0.82) |
| Smoking | −1.96 (0.05) | −0.40 (0.69) | −0.67 (0.51) |
| Baseline | |||
| AFEQT | −0.47 (<0.01) | −0.10 (0.37) | −0.13 (0.25) |
| PCS | −0.22 (0.05) | −0.34 (<0.01) | 0.20 (0.08) |
| MCS | −0.12 (0.30) | 0.16 (0.17) | −0.54 (<0.01) |
| Three-month outcome | −5.79 (<0.01) | −2.39 (0.02) | −2.72 (<0.01) |
AF, atrial fibrillation; AFEQT, Atrial Fibrillation Effect on Quality-of-Life; LA, left atrial; LVEF, left ventricular ejection fraction; MCS, mental component summary; PCS, physical component summary.
R values from Pearson's correlation (continuous variables) and T values from independent t tests (categorical variables) are shown.